TipRanks
Arovella Therapeutics Limited (DE:E4NA)
FRANKFURT:E4NA
Germany Market
E4NA
Arovella Therapeutics Limited
RESEARCH TOOLSreports

Arovella Therapeutics Limited (E4NA) Stock News & Sentiment

0 Followers
Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial
Premium
Company Announcements
Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial
2d ago
Arovella Deepens ESG Commitment Ahead of Australia’s Sustainability Rules
Premium
Company Announcements
Arovella Deepens ESG Commitment Ahead of Australia’s Sustainability Rules
16d ago
Arovella Sets Hybrid 2026 AGM and Shifts to Default Digital Communications
Premium
Company Announcements
Arovella Sets Hybrid 2026 AGM and Shifts to Default Digital Communications
24d ago
Arovella Details Governance Framework in 2026 Corporate Statement
Premium
Company Announcements
Arovella Details Governance Framework in 2026 Corporate Statement
1M ago
Arovella lodges 2026 corporate governance statement and Appendix 4G
Premium
Company Announcements
Arovella lodges 2026 corporate governance statement and Appendix 4G
1M ago
Arovella Narrows Annual Loss as Net Tangible Assets Per Share Fall
Premium
Company Announcements
Arovella Narrows Annual Loss as Net Tangible Assets Per Share Fall
1M ago
Arovella Issues 9.7 Million Unquoted Options Under Employee Incentive Scheme
Premium
Company Announcements
Arovella Issues 9.7 Million Unquoted Options Under Employee Incentive Scheme
2M ago
More DE:E4NA News >

E4NA News on the Web

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial
TipRanks News
Bullish
Arovella Deepens ESG Commitment Ahead of Australia’s Sustainability Rules
TipRanks News
Neutral
Health Check: EMVision achieves back-of-the-ambo stroke breakthrough
StockHead
Bullish
Arovella Sets Hybrid 2026 AGM and Shifts to Default Digital Communications
TipRanks News
Neutral
Health Check: We’ll focus on the #8216;mundane#8217; stuff to drive sales, promises Micro-X’s new chief
StockHead
Neutral
Health Check: Testosterone boost for erectile dysfunction house
StockHead
Neutral
Arovella Surges as Fresh Staff Options Signal Ambition
TipRanks News
Neutral
Arovella Issues 9.7 Million Unquoted Options Under Employee Incentive Scheme
TipRanks News
Neutral

News Score - Last 7 Days

Positive
DE:E4NA
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:E4NA’s Media Buzz Sentiment?
2 articles about DE:E4NA were published this week. In an average week, 1.75 articles are published.
    What is DE:E4NA’s weekly average amount of articles?
    In an average week, 1.75 articles about DE:E4NA are published.
      What is DE:E4NA’s News Sentiment?
      100% of articles about DE:E4NA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        HUMHumana
        ACETAdicet Bio
        ZYMEZymeworks
        RHHBYRoche Holding
        QTTBQ32 Bio
        Showing the stocks with the most bullish news sentiment over the past week